How much revenue did CSL generate this year?
CSL has achieved a revenue of 14.86 B USD this year.
CSL Revenue 2024
CSL Revenue
14.86 B USD
CSL Dividend yield
2.01 %
Ticker
CSL.AX
ISIN
AU000000CSL8
WKN
890952
In 2024, CSL's sales reached 14.86 B USD, a 11.64% difference from the 13.31 B USD sales recorded in the previous year.
The CSL Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2030e | 25.15 | 27,21 |
| 2029e | 22.21 | 30,82 |
| 2028e | 20.04 | 34,16 |
| 2027e | 18.62 | 36,76 |
| 2026e | 17.25 | 39,67 |
| 2025e | 16.08 | 42,55 |
| 2024e | 14.86 | 46,06 |
| 2023 | 13.31 | 51,42 |
| 2022 | 10.56 | 54,27 |
| 2021 | 10.31 | 56,68 |
| 2020 | 9.15 | 57,11 |
| 2019 | 8.54 | 55,95 |
| 2018 | 7.92 | 55,38 |
| 2017 | 6.92 | 51,94 |
| 2016 | 6.12 | 50,08 |
| 2015 | 5.63 | 53,70 |
| 2014 | 5.52 | 52,86 |
| 2013 | 5.13 | 53,38 |
| 2012 | 4.77 | 50,39 |
| 2011 | 4.26 | 50,74 |
| 2010 | 4.06 | 52,59 |
| 2009 | 3.69 | 52,21 |
| 2008 | 3.4 | 49,17 |
| 2007 | 2.6 | 47,56 |
| 2006 | 2.17 | 41,39 |
| 2005 | 2.45 | 48,15 |
| 2004 | 1.31 | 41,71 |
CSL Aktienanalyse
What does CSL do?
CSL Ltd is a global leading company in the field of biological medicine, manufacturing a wide range of products used in the therapy of diseases. The company is based in Melbourne, Australia, and is one of the largest biotech companies in the country. CSL was founded in 1916 by Australian researcher Frank Macfarlane Burnet. Originally named Commonwealth Serum Laboratories, the company focused on the research and production of vaccines. CSL was then privatized in 1994 and changed its name to CSL Ltd. CSL's business model is based on the production of protein products and plasma derivatives used in immunotherapy, hematology, and transplantation medicine. The company specializes in the production and marketing of products in three main areas: plasma products, vaccines, and animal health. CSL's plasma division includes a variety of products, including intravenous immunoglobulins (IVIG), platelets, and alpha-1 antitrypsin. The company operates a number of plasma centers in the US and Europe to collect raw materials for these products. In the vaccine sector, CSL is primarily involved in the manufacture of influenza vaccines and also offers a range of other vaccines, including vaccines against snake bites and encephalitis. In the field of animal health, CSL produces animal vaccines to prevent viral infections in livestock such as pigs, poultry, and cattle. CSL is committed to research and development to develop new products and improve existing ones. The company has a long history in the research and development of vaccines and immunotherapies and has established a strong presence in this field. The company employs over 27,000 people in 35 countries worldwide and operates production facilities in Australia, the US, Europe, and Asia. CSL's headquarters are located in Parkville, a suburb of Melbourne, Australia. CSL has an impressive track record in terms of growth and profitability and is a stable market leader in its field. The company has achieved solid growth rates in recent years and generated a revenue of $8.5 billion in 2019. CSL is a key player in the global healthcare industry and has established a reputation as a reliable supplier of medical products and services. The company is committed to developing innovative solutions to advance medical progress and make a positive contribution to human health. CSL ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding CSL's Sales Figures
The sales figures of CSL originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing CSL’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize CSL's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in CSL’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about CSL Stock
How much was the turnover of the company CSL compared to the previous year?
The revenue of CSL has increased by 11.64% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of CSL?
The revenue of CSL is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of CSL measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of CSL so important for investors?
The revenue of CSL is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does CSL pay?
Over the past 12 months, CSL paid a dividend of 3.72 USD . This corresponds to a dividend yield of about 2.01 %. For the coming 12 months, CSL is expected to pay a dividend of 3.92 USD.
What is the dividend yield of CSL?
The current dividend yield of CSL is 2.01 %.
When does CSL pay dividends?
CSL pays a quarterly dividend. This is distributed in the months of October, April, October, April.
How secure is the dividend of CSL?
CSL paid dividends every year for the past 27 years.
What is the dividend of CSL?
For the upcoming 12 months, dividends amounting to 3.92 USD are expected. This corresponds to a dividend yield of 2.12 %.
In which sector is CSL located?
CSL is assigned to the 'Health' sector.
Wann musste ich die Aktien von CSL kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of CSL from 4/3/2024 amounting to 1.799 USD, you needed to have the stock in your portfolio before the ex-date on 3/11/2024.
When did CSL pay the last dividend?
The last dividend was paid out on 4/3/2024.
What was the dividend of CSL in the year 2023?
In the year 2023, CSL distributed 3.257 USD as dividends.
In which currency does CSL pay out the dividend?
The dividends of CSL are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The CSL stock can be added to a savings plan with the following providers: Consorsbank
Andere Kennzahlen von CSL
Our stock analysis for CSL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CSL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
